CLINICAL_TRIALS
trial_result
· 2017-02-08
Clinical Trial Update: Ketamine For Suicidal Ideation [Phase 4]
Summary
This update reports the completion and posted results of a Phase 4 trial evaluating ketamine for reducing suicidal ideation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: James Murrough | Conditions: Suicidal Ideation | Phase 4 | Status: COMPLETED | Results posted: 2017-02-08